A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)

Condition:   Primary Hypercholesterolemia Interventions:   Drug: Ezetimibe;   Drug: Placebo;   Drug: Simivastatin;   Drug: Statin Sponsor:   Merck Sharp & Dohme Corp. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials